Literature DB >> 22424017

Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States.

Daniel W Mudrick1, Patricia A Cowper, Bimal R Shah, Manesh R Patel, Neil C Jensen, Eric D Peterson, Pamela S Douglas.   

Abstract

BACKGROUND: Millions of Americans with suspected coronary artery disease undergo noninvasive cardiac stress testing annually. Downstream procedures and subsequent outcomes among symptomatic patients without known coronary disease referred for stress testing are not well characterized in contemporary community practice.
METHODS: We examined administrative insurance billing data from a national insurance provider from November 2004 through June 2007. After excluding patients with prior cardiac disease or chest pain evaluation, we identified 80,676 people age 40 to 64 years with outpatient cardiac stress testing within 30 days after an office visit for chest pain. We evaluated rates of invasive coronary angiography, coronary revascularization, and cardiovascular events after stress testing.
RESULTS: Within 60 days, only 8.8% of stress test patients underwent cardiac catheterization and only 2.7% underwent revascularization; within 1 year, only 0.5% died and had myocardial infarction or stroke. There were marked geographic variations in 1-year rates of catheterization (3.8%-14.8%) and revascularization (1.2%-3.0%) across 20 hospital referral regions.
CONCLUSIONS: In this large national cohort of middle-aged patients without previously coded cardiac diagnosis who were referred for stress testing after outpatient chest pain evaluation, few proceeded to invasive angiography or revascularization, and subsequent cardiovascular events were infrequent. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424017      PMCID: PMC3886123          DOI: 10.1016/j.ahj.2011.11.022

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  31 in total

1.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

2.  Elements of danger--the case of medical imaging.

Authors:  Michael S Lauer
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

3.  Prognostic importance of dipyridamole-echocardiography test in coronary artery disease.

Authors:  E Picano; S Severi; C Michelassi; F Lattanzi; M Masini; E Orsini; A Distante; A L'Abbate
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

4.  A clinically relevant classification of chest discomfort.

Authors:  G A Diamond
Journal:  J Am Coll Cardiol       Date:  1983-02       Impact factor: 24.094

5.  The threshold approach to clinical decision making.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1980-05-15       Impact factor: 91.245

6.  Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

Authors:  K E Fleischmann; M G Hunink; K M Kuntz; P S Douglas
Journal:  JAMA       Date:  1998-09-09       Impact factor: 56.272

7.  Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease.

Authors:  Sripal Bangalore; Devi Gopinath; Siu-Sun Yao; Farooq A Chaudhry
Journal:  J Am Soc Echocardiogr       Date:  2007-03       Impact factor: 5.251

8.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease.

Authors:  D B Mark; L Shaw; F E Harrell; M A Hlatky; K L Lee; J R Bengtson; C B McCants; R M Califf; D B Pryor
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

9.  Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era.

Authors:  F L Lucas; A E Siewers; D J Malenka; D E Wennberg
Journal:  Circulation       Date:  2008-12-08       Impact factor: 29.690

10.  Use of the Social Security Administration Death Master File for ascertainment of mortality status.

Authors:  Enrique F Schisterman; Brian W Whitcomb
Journal:  Popul Health Metr       Date:  2004-03-05
View more
  18 in total

1.  Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Christopher B Fordyce; Pamela S Douglas; Rhonda S Roberts; Udo Hoffmann; Hussein R Al-Khalidi; Manesh R Patel; Christopher B Granger; John Kostis; Daniel B Mark; Kerry L Lee; James E Udelson
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

2.  Yield of downstream tests after exercise treadmill testing: a prospective cohort study.

Authors:  Mitalee P Christman; Marcio Sommer Bittencourt; Edward Hulten; Ekta Saksena; Jon Hainer; Hicham Skali; Raymond Y Kwong; Daniel E Forman; Sharmila Dorbala; Patrick T O'Gara; Marcelo F Di Carli; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2014-02-05       Impact factor: 24.094

Review 3.  Outcomes of anatomical vs. functional testing for coronary artery disease : Lessons from the major trials.

Authors:  Júlia Karády; Jana Taron; Andreas Anselm Kammerlander; Udo Hoffmann
Journal:  Herz       Date:  2020-08       Impact factor: 1.443

4.  Outcomes of anatomical versus functional testing for coronary artery disease.

Authors:  Pamela S Douglas; Udo Hoffmann; Manesh R Patel; Daniel B Mark; Hussein R Al-Khalidi; Brendan Cavanaugh; Jason Cole; Rowena J Dolor; Christopher B Fordyce; Megan Huang; Muhammad Akram Khan; Andrzej S Kosinski; Mitchell W Krucoff; Vinay Malhotra; Michael H Picard; James E Udelson; Eric J Velazquez; Eric Yow; Lawton S Cooper; Kerry L Lee
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

Review 5.  False-Positive Stress Echocardiograms: A Continuing Challenge.

Authors:  Salima Qamruddin
Journal:  Ochsner J       Date:  2016

6.  Coronary CT Angiography as a Diagnostic and Prognostic Tool: Perspective from a Multicenter Randomized Controlled Trial: PROMISE.

Authors:  Daniel O Bittner; Maros Ferencik; Pamela S Douglas; Udo Hoffmann
Journal:  Curr Cardiol Rep       Date:  2016-05       Impact factor: 2.931

7.  Hospital variation in the use of noninvasive cardiac imaging and its association with downstream testing, interventions, and outcomes.

Authors:  Kyan C Safavi; Shu-Xia Li; Kumar Dharmarajan; Arjun K Venkatesh; Kelly M Strait; Haiqun Lin; Timothy J Lowe; Reza Fazel; Brahmajee K Nallamothu; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

8.  PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial.

Authors:  Pamela S Douglas; Udo Hoffmann; Kerry L Lee; Daniel B Mark; Hussein R Al-Khalidi; Kevin Anstrom; Rowena J Dolor; Andrzej Kosinski; Mitchell W Krucoff; Daniel W Mudrick; Manesh R Patel; Michael H Picard; James E Udelson; Eric J Velazquez; Lawton Cooper
Journal:  Am Heart J       Date:  2014-03-18       Impact factor: 4.749

Review 9.  Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies.

Authors:  Jamieson M Bourque; George A Beller
Journal:  JACC Cardiovasc Imaging       Date:  2015-11

10.  Appropriateness vs value: Echocardiography in primary care.

Authors:  Amy Bethge; Oana Penciu; Salma Baksh; Swapnil Parve; Jessika Lobraico; Andrew M Keller
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.